Skip to content
sellModerate cluster of 3

Machelle Sanders sold $28k of BCRX

director at BIOCRYST PHARMACEUTICALS INC. 4,689 shares at an average of $6.00, traded Jun 17, 2024, filed Jun 17, 2024.

Warning score
40
Value
$28k
4,689 shares
Holdings after
27,742
-14% from before
From 52-week low
+51%
low $4.13, close $6.24
From 52-week high
-21%
high $7.92, as of Jun 17, 2024

Score components

  • Role
    Director
    +15
  • Trade size
    $28k at market
    +5
  • Share of holdings sold
    Sold 14% of holdings
    +5
  • Cluster
    3 insiders selling within 14 days
    +15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +16.5%, 3m +26.8%, 6m +19.6%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

BCRXOct 13, 2026 · close 8.07
Since filing Jun 17, 2024: +29.3%SPY +46.4% · excess -17.1%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001127602-24-018846, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jun 17, 2024SOpen-market sale
Common Stock
-4,689$6.00$28k27,742Jun 17, 2024

Related signals

Other insiders at BIOCRYST PHARMACEUTICALS INC and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
43Moderate
BCRXsell 2
BIOCRYST PHARMACEUTICALS INC
Amy E McKee
director
$100k
11,180 shares
-26%
12Weak
BCRXsell 210b5-1
BIOCRYST PHARMACEUTICALS INC
Alane P Barnes
Chief Legal Officer
$596k
62,500 shares
-13%
36Weak
BCRXsell 2
BIOCRYST PHARMACEUTICALS INC
Theresa Heggie
director
$505k
49,933 shares
-43%
23Weak
BCRXsell 210b5-1
BIOCRYST PHARMACEUTICALS INC
Alane P Barnes
Chief Legal Officer
$1.4M
150,000 shares
-27%
6Weak
BCRXsell10b5-1
BIOCRYST PHARMACEUTICALS INC
Alane P Barnes
Chief Legal Officer
$167k
21,773 shares
-5%
6Weak
BCRXsell10b5-1
BIOCRYST PHARMACEUTICALS INC
Alane P Barnes
Chief Legal Officer
$162k
21,210 shares
-6%
15Weak
BCRXsell10b5-1
BIOCRYST PHARMACEUTICALS INC
Alane P Barnes
Chief Legal Officer
$1.2M
161,680 shares
-32%
8Weak
BCRXsell10b5-1
BIOCRYST PHARMACEUTICALS INC
Machelle Sanders
director
$69k
9,600 shares
-24%
39Weak
BCRXsell
BIOCRYST PHARMACEUTICALS INC
Theresa Heggie
director
$596k
70,000 shares
-52%
2Weak
BCRXsell10b5-1
BIOCRYST PHARMACEUTICALS INC
Nancy J Hutson
director
$53k
7,000 shares
-7%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.